• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D/A filed by BJ's Restaurants Inc. (Amendment)

    2/21/24 6:39:54 PM ET
    $BJRI
    Restaurants
    Consumer Discretionary
    Get the next $BJRI alert in real time by email
    SC 13D/A 1 bjsr13da1-02212024.htm
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13D
    Under the Securities Exchange Act of 1934
    (Amendment No. 1 )


    BJ’s Restaurants, Inc.
    (Name of Issuer)


    Common Stock, no par value
    (Title of Class of Securities)

    09180C106
    (CUSIP Number)

    Christopher P. Davis
    Kleinberg, Kaplan, Wolff & Cohen, P.C.
    500 Fifth Avenue
    New York, NY 10110
    (212) 986-6000

    (Name, Address and Telephone Number of Person
    Authorized to Receive Notices and Communications)

    February 16, 2024
    (Date of Event which Requires Filing of this Statement)

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box [ ].



    1
    NAME OF REPORTING PERSONS
     
    Fund 1 Investments, LLC
     
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
    (a)    [  ]
    (b)    [  ]
     
    3
    SEC USE ONLY
     
      
    4
    SOURCE OF FUNDS (See Instructions)
    AF
    5
    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) [   ]
     
     
    6
    CITIZENSHIP OR PLACE OF ORGANIZATION
    Delaware
    NUMBER OF SHARES
    BENEFICIALLY
    7
    SOLE VOTING POWER
    2,568,476
    OWNED BY
    EACH
    REPORTING
    8
    SHARED VOTING POWER
    0
    PERSON
    WITH
     
    9
    SOLE DISPOSITIVE POWER
    2,568,476
     
    10
    SHARED DISPOSITIVE POWER
    0
    11
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     2,568,476
    12
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11)
    EXCLUDES CERTAIN SHARES    [ ]
    13
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
    11.1%
    14
    TYPE OF REPORTING PERSON (See Instructions)
    OO (Limited Liability Company), HC (Parent Holding Company)

    The following constitutes Amendment No. 1 (“Amendment No. 1”) to the Schedule 13D previously filed by the undersigned on January 18, 2024 (the “Schedule 13D”). This Amendment No. 1 amends the Schedule 13D as specifically set forth herein.  Each capitalized term used and not defined herein shall have the meaning assigned to such term in the Schedule 13D. Except as provided herein, each Item of the Schedule 13D remains unchanged.

    Item 3. Source and Amount of Funds or Other Consideration.

    Item 3 of the Schedule 13D is hereby amended and restated in its entirety as follows:

    The total amount of funds used by the Reporting Person to make all purchases of Shares beneficially owned by the Reporting Person, as reported in Item 5(a,b) was $79,176,767.37. The source of funds for purchases of Shares by the Reporting Person is the working capital of the Funds.

    Item 5. Interest in Securities of the Issuer
    Item 5 of the Schedule 13D is hereby amended and restated in its entirety as follows:

    (a)            The aggregate percentage of Shares reported owned by the Reporting Person is based upon 23,236,999 Shares outstanding as of November 3, 2023, which is the total number of Shares outstanding as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 6, 2023.
    As of the close of business on the date hereof, the Reporting Person beneficially owned 2,568,476 Shares, constituting approximately 11.1% of all of the outstanding Shares.
    (b)            The Reporting Person has sole power (i) to vote or direct the vote of, and (ii) to dispose or direct the disposition of, the 2,568,476 Shares held by the Funds.
    (c) During the past sixty (60) days, the Reporting Person has not entered into any transactions in the Shares except as set forth on Schedule 1 hereto.
    (d) Pleasant Lake Onshore Feeder Fund, LP has the right to receive or the power to direct the receipt of distributions or dividends from, or the proceeds from the transfer of, the reported securities.

    (e) Not Applicable.

    Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.
     
    Item 6 of the Schedule 13D is hereby amended and restated in its entirety as follows:

    Not Applicable.



    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, each of the undersigned certifies that the information set forth in the Statement is true, complete and correct.

    Dated: February 21, 2024

    FUND 1 INVESTMENTS, LLC
     
     
       
    By:
    /s/ Benjamin C. Cable
     
     
    Benjamin C. Cable
    Chief Operating Officer
     




    SCHEDULE 1
    Transactions in the Common Stock of the Issuer by Reporting Person During the Past 60 Days:
    Date
    Buy/Sell
    Security
    Approximate
    Price Per Share or Option,
    as Applicable1
    Number of Shares Bought/(Sold)
    or Underlying Options
                 
    12/29/2023
    BUY
    Common Stock
    $36.8256
     
    3,000
     
    12/29/2023
    SELL
    Common Stock
    $36.5400
     
    (1,000)
     
    12/29/2023
    SELL
    Common Stock
    $36.2987
     
    (3,860)
     
    01/02/2024
    BUY
    Common Stock
    $35.6473
     
    5,500
     
    01/02/2024
    SELL
    Common Stock
    $35.1100
     
    (500,000)
     
    01/03/2024
    BUY
    Common Stock
    $33.2533
     
    41,100
     
    01/04/2024
    BUY
    Common Stock
    $32.6692
     
    8,500
     
    01/05/2024
    BUY
    Common Stock
    $32.4747
     
    17,960
     
    01/08/2024
    BUY
    Common Stock
    $33.1036
     
    4,000
     
    01/09/2024
    BUY
    Common Stock
    $32.9149
     
    44,771
     
    01/10/2024
    BUY
    Common Stock
    $32.7500
     
    2,000
     
    01/10/2024
    BUY
    Common Stock
    $32.8281
     
    7,600
     
    01/11/2024
    BUY
    Common Stock
    $32.3249
     
    25,000
     
    01/11/2024
    BUY
    Common Stock
    $32.7814
     
    4,500
     
    01/11/2024
    BUY
    Common Stock
    $31.9952
     
    62,115
     
    01/12/2024
    BUY
    Common Stock
    $32.3874
     
    20,000
     
    01/12/2024
    BUY
    Common Stock
    $31.8720
     
    59,500
     
    01/16/2024
    BUY
    Common Stock
    $31.4445
     
    25,000
     
    01/17/2024
    BUY
    Common Stock
    $30.5453
     
    55,500
     
    01/19/2024
    BUY
    Common Stock
    $30.0000
     
    900,0002
     
    01/31/2024
    BUY
    Common Stock
    $35.3483
     
    116,000
     
    02/16/2024
    BUY
    Common Stock
    $36.4077
     
    250,000
     
                 
                 
                 






    1 Excluding any brokerage fees.
    2 Exercise of options, no change in beneficial ownership number.
    Get the next $BJRI alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $BJRI

    DatePrice TargetRatingAnalyst
    1/8/2025$36.00Underperform → Hold
    Gordon Haskett
    1/7/2025Outperform → Perform
    Oppenheimer
    7/26/2024Buy → Hold
    The Benchmark Company
    7/18/2023$35.00Neutral
    Piper Sandler
    4/18/2023$36.00Neutral → Outperform
    Wedbush
    12/20/2022$36.00Buy
    CL King
    9/23/2022$27.00Equal-Weight
    Stephens
    4/12/2022$29.00Neutral
    Citigroup
    More analyst ratings